TG Therapeutics Inc (TGTX)
Number of days of payables
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
September 30, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The number of days of payables for TG Therapeutics Inc is not available in the provided data for the specified periods. Therefore, without this specific information, it is not possible to analyze the company's payment practices in terms of the average number of days it takes for the company to pay its outstanding payables. To conduct a thorough analysis of the company's payables management efficiency and liquidity position, the availability of this data is essential.
Peer comparison
Sep 30, 2024
Company name
Symbol
Number of days of payables
TG Therapeutics Inc
TGTX
—
Abbott Laboratories
ABT
49.95
AbbVie Inc
ABBV
36.53
Alkermes Plc
ALKS
19.63
Amphastar P
AMPH
31.66
ANI Pharmaceuticals Inc
ANIP
33.22
Arcus Biosciences Inc
RCUS
50.86
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
42.27
Catalent Inc
CTLT
39.59
Catalyst Pharmaceuticals Inc
CPRX
26.83